After Pharmacyclics, Who’s Next in Biotech M&A?
March 05, 2015 at 11:50 AM EST
Following AbbVie’s (ABBV) takeout of Pharmacyclics (PCYC), expect more M&A in the biotech space. RBC’s Joseph Schwartz speculate as to which biotechs might be next: Sipa via AP Images We believe that partnership and acquisition (P&A) activity is likely to remain a key feature of newsflow and excess returns for investors in the biopharma industry…We highlight 8 [...]
